The Asia Pacific vaccine market has witnessed significant growth, driven by a combination of factors, including the rising prevalence of infectious diseases, advancements in vaccine technologies, and the increasing importance of immunization programs across the region. Valued at approximately USD 4.56 billion in 2023, the market is poised to expand at a CAGR of 7.8% during the forecast period...